A 44-year-old female presented to a cancer clinic in 1994 for follow-up after a recent right segmental mastectomy for a grade I infiltrating ductal breast carcinoma. Initial staging work-up had ...

Background. Sarcoidosis is a multisystemic granulomatous disease of unknown origin that affects individuals worldwide, with highest incidence and prevalence in African Americans.1 It is characterised ...

Parakeratosis pustulosa (PP) is a cause of distal nail inflammation and nail dystrophy that affects a single digit. It is nonpruritic and minimally painful. This distal digital dactylitis is ...

A disease with no known cause. Sarcoidosis is a disease of unknown origin that causes the immune system to overreact, leading to lung damage, skin rashes and other organ damage. This once rare disease ...

Objectives To update the Assessment of SpondyloArthritis international Society (ASAS)-EULAR recommendations for the management of axial spondyloarthritis (axSpA). Methods Following the EULAR ...

Objective To identify clusters of peripheral involvement according to the specific location of peripheral manifestations (ie, arthritis, enthesitis and dactylitis) in patients with spondyloarthritis ...

Objective To evaluate the efficacy and safety of an oral selective tyrosine kinase 2 (TYK2) inhibitor, deucravacitinib, in patients with active psoriatic arthritis (PsA). Methods In this double-blind, ...

Treatment retention was compared by drug survival analysis.Results 69% of the patients (n=900) started b/tsDMARD as monotherapy while 31% were treated in combination with MTX (n=405). At baseline, ...

Background and aims Sarcoidosis is characterised by a compartmentalisation of CD4+ T helper 1 (Th1) lymphocytes and activated macrophages in involved organs, including the lung. Recently, Th17 ...

Axial spondyloarthritis (axSpA), which includes both non-radiographic axSpA (nr-axSpA) and ankylosing spondylitis (AS), is a chronic, immune-mediated, inflammatory disease. 7 nr-axSpA is defined ...